Conroy Kevin T. - 27 Feb 2026 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark Busch, attorney-in- fact
Issuer symbol
EXAS
Transactions as of
27 Feb 2026
Net transactions value
-$3,304,723
Form type
4
Filing time
03 Mar 2026, 19:16:40 UTC
Previous filing
27 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Conroy Kevin T President and CEO, Director C/O EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON /s/ Kevin T. Conroy by Mark Busch, attorney-in- fact 03 Mar 2026 0001306119

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +18,143 +1.5% $0.000000 1,260,098 27 Feb 2026 Direct F1
transaction EXAS Common Stock Tax liability $880,516 -8,528 -0.68% $103.25 1,251,570 27 Feb 2026 Direct F2
transaction EXAS Common Stock Options Exercise $0 +22,168 +1.8% $0.000000 1,273,738 27 Feb 2026 Direct F1
transaction EXAS Common Stock Tax liability $1,075,762 -10,419 -0.82% $103.25 1,263,319 27 Feb 2026 Direct F2
transaction EXAS Common Stock Options Exercise $0 +27,786 +2.2% $0.000000 1,291,105 27 Feb 2026 Direct F1
transaction EXAS Common Stock Tax liability $1,348,445 -13,060 -1% $103.25 1,278,045 27 Feb 2026 Direct F2, F3
holding EXAS Common Stock 29,061 27 Feb 2026 Held in 401(k) Plan
holding EXAS Common Stock 46,538 27 Feb 2026 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 86,750 27 Feb 2026 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 117,427 27 Feb 2026 Held in Grantor Retained Annuity Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Options Exercise $0 -18,143 -50% $0.000000 18,143 27 Feb 2026 Common Stock 18,143 Direct F4, F5
transaction EXAS Restricted Stock Units Options Exercise $0 -22,168 -33% $0.000000 44,336 27 Feb 2026 Common Stock 22,168 Direct F4, F6
transaction EXAS Restricted Stock Units Options Exercise $0 -27,786 -25% $0.000000 83,360 27 Feb 2026 Common Stock 27,768 Direct F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 1,557,821 shares, Mr. Conroy also holds, in the aggregate, an additional 737,129 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 Represents a restricted stock unit award granted on February 24, 2023 that partially vested on February 27, 2026. The restricted stock units vest in four equal annual installments on the last trading day of February.
F6 Represents a restricted stock unit award granted on February 26, 2024 that partially vested on February 27, 2026. The restricted stock units vest in four equal annual installments on the last trading day of February.
F7 Represents a restricted stock unit award granted on February 24, 2025 that partially vested on February 27, 2026. The restricted stock units vest in four equal annual installments on the last trading day of February.